Serum sirtuin1: a potential blood biomarker for early diagnosis of Alzheimer’s disease
Open Access
- 22 September 2023
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 15 (18) , 9464-9478
Abstract
Background: Sirtuin 1, a nicotinamide adenine dinucleotide-dependent deacetylase that is highly expressed in the hippocampus and anterior cortex tissues related to Alzheimer’s Disease pathology, can cross the blood-brain barrier and is a promising biomarker. Methods: A 1:1:1 case-control study was conducted and serum fasting blood glucose, triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, SIRT1, IL-6, Aβ1-42, T-tau and P-tau-181 levels were evaluated in blood samples of 26 patients form the Alzheimer’s Disease group, 26 patients form the mild cognitive impairment group, and 26 individuals form the normal control group. Receiver operator characteristic curves were used to evaluate the diagnostic significance. Results: Serum SIRT1 level was significantly down-regulated in the mild cognitive impairment patients and Alzheimer’s Disease patients compared with that in the normal control group (P<0.05). ROC curve analysis demonstrated that SIRT1 was a promising biomarker to distinguish Alzheimer’s Disease patients from the mild cognitive impairment patients and the normal control group. In addition, SIRT1 was estimated to perform well in the diagnosis of Alzheimer’s Disease ([AUC] = 0.742). Conclusions: In summary, the present study suggested that serum SIRT1 might be an early promising diagnostic biomarker for Alzheimer’s Disease.Keywords
This publication has 51 references indexed in Scilit:
- Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive ImpairmentInternational Journal of Molecular Sciences, 2019
- Circular HDAC9/microRNA-138/Sirtuin-1 Pathway Mediates Synaptic and Amyloid Precursor Protein Processing Deficits in Alzheimer’s DiseaseNeuroscience Bulletin, 2019
- Arterial SystemHypertension, 2018
- KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cellsActa Pharmacologica Sinica, 2018
- Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injuryJournal of Neuroinflammation, 2018
- Biosensors for Alzheimer's disease biomarker detection: A reviewBiochimie, 2018
- Mild Cognitive ImpairmentClinics in Geriatric Medicine, 2017
- Sirtuin1: A Promising Serum Protein Marker for Early Detection of Alzheimer’s DiseasePLOS ONE, 2013
- Abnormal Cortical Networks in Mild Cognitive Impairment and Alzheimer's DiseasePLOS Computational Biology, 2010
- Eighteenth Meeting of the European Neurological Society 7–11 June 2008, Nice, FranceJournal of Neurology, 2008